The Latest Breaking News from Vaccine

Tackling African swine fever – which has led to death of more than 100m pigs since 2018 – has proved a tougher challenge than scientists first thought

The Food and Drug Administration has authorized a booster dose of the COVID-19 vaccine made by Novavax

Pfizer’s (PFE) co-developed COVID-19 vaccine booster for children, which recently got Emergency Use Authorization from the U.S. FDA, could boost its share price. The stock had witnessed significant attention during the pandemic and could still be worth owning. Let’s discuss this in detail….

Someone perhaps most deserving of a Nobel Prize for his work in virology never got it. Who was Louis Pasteur?

Health officials blamed the country’s poor sanitation and crumbling infrastructure, as the disease spreads from Syria.

Novavax won Food and Drug Administration for its Covid booster on Wednesday, but NVAX stock dipped slightly in response.

There are fears of a "twindemic" of Covid and flu this winter

The World Health Organization and its partners are recommending that countries temporarily switch to using a single dose of the cholera vaccine instead of two due to a global supply shortage

Health officials halve dose to eke out ‘extremely limited’ supply amid unprecedented rise in outbreaks

The World Health Organization said on Wednesday it will temporarily suspend the standard two-dose vaccination regimen for cholera, replacing it with a single dose due to vaccine shortages and rising outbreaks worldwide.

The main Covid-19 booster offers good protection for at least three months.